Page 88 - Overall Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Overall coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Overall Coverage Today - Breaking & Trending Today

Japan Overall Bank Lending Climbs 6.2% On Year In December

TOKYO (dpa-AFX) - The value of overall bank lending in Japan was up 6.2 percent on year in December, the Bank of Japan said on Tuesday - coming in at 577.639 trillion yen.That's unchanged from ....

Kostenloser Wertpapierhandel ,

F. Hoffmann-La Roche Ltd: Roche to present updated data confirming Tecentriq in combination with Avastin substantially improves overall survival in people with the most common form of liver cancer


F. Hoffmann-La Roche Ltd: Roche to present updated data confirming Tecentriq in combination with Avastin substantially improves overall survival in people with the most common form of liver cancer
19.2
6.9
18.1
Tecentriq + Avastin (n=133)
24.0
(0.35-0.80)
Median follow-up: 15.6 months.
CR, complete response; DOR, duration of response; HR, hazard ratio; NE, not estimable; ORR, objective response rate; OS, overall survival; PFS, progression free response; PR, partial response; SD, stable disease.
See below for OS data from the primary analysis.
About the IMbrave150 study
IMbrave150 is a global Phase III, multicentre, open-label study of 501 people with unresectable HCC who had not received prior systemic therapy. People were randomised 2:1 to receive the combination of Tecentriq and Avastin or sorafenib. Tecentriq was administered intravenously (IV), 1200 mg on day 1 of each 21-day cycle, and Avastin was administered IV, 15 mg/kg on day ....

United States , Laura Kulik , Nathalie Meetz , Levi Garraway , Daniel Grotzky , Jon Kaspar Bayard , Karl Mahler , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Lisa Tuomi , Loren Kalm , Patrick Barth , Karsten Kleine , American Society Of Clinical Oncology , Head Of Global Product Development , World Health Organisation , Roche Group , Feinberg School Of Medicine , Pharmaceuticals Industry , Roche Group Media Relations , Northwestern University , American Cancer Society , Cancers Symposium , American Society ,